Yunnan Botanee Bio-Technology GroupLTD (SZSE:300957) Stock Valuation, Peer Comparison & Price Targets

Q: What is the Fair Price of 300957 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

300957 (CN¥47.9) is trading below our estimate of [[fair value]] (CN¥60.55)

Share Price vs Fair Value

What is the Fair Price of 300957 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 300957 (CN¥47.9) is trading below our estimate of fair value (CN¥60.55)

Significantly Below Fair Value: 300957 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 300957?

Key metric: As 300957 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 300957. This is calculated by dividing 300957's market cap by their current earnings.
What is 300957's PE Ratio?
PE Ratio	34x
Earnings	CN¥592.37m
Market Cap	CN¥21.27b

300957 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	3.1x
Enterprise Value/EBITDA	38.6x
PEG Ratio	1x

Price to Earnings Ratio vs Peers

How does 300957's PE Ratio compare to its peers?

The above table shows the PE ratio for 300957 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	32x
300146 Byhealth	29.3x	34.8%	CN¥20.9b
603868 Shanghai Flyco Electrical Appliance	26.7x	16.0%	CN¥17.5b
603983 Guangdong Marubi Biotechnology	34.2x	24.0%	CN¥11.1b
003006 Chongqing Baiya Sanitary Products	37.8x	26.1%	CN¥11.1b
300957 Yunnan Botanee Bio-Technology GroupLTD	34x	33.3%	CN¥20.1b

Price-To-Earnings vs Peers: 300957 is expensive based on its Price-To-Earnings Ratio (34x) compared to the peer average (32x).

Price to Earnings Ratio vs Industry

How does 300957's PE Ratio compare vs other companies in the CN Personal Products Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 300957 is good value based on its Price-To-Earnings Ratio (34x) compared to the CN Personal Products industry average (35.1x).

Price to Earnings Ratio vs Fair Ratio

What is 300957's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

300957 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	34x
Fair PE Ratio	35.6x

Price-To-Earnings vs Fair Ratio: 300957 is good value based on its Price-To-Earnings Ratio (34x) compared to the estimated Fair Price-To-Earnings Ratio (35.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 300957 forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	CN¥47.90	CN¥63.27 +32.1%	26.0%	CN¥109.00	CN¥43.00	n/a	16
Nov ’25	CN¥52.34	CN¥63.34 +21.0%	25.9%	CN¥109.00	CN¥43.00	n/a	16
Oct ’25	CN¥62.42	CN¥63.51 +1.8%	26.9%	CN¥109.00	CN¥43.00	n/a	15
Sep ’25	CN¥42.05	CN¥67.17 +59.7%	21.2%	CN¥109.00	CN¥50.00	n/a	15
Aug ’25	CN¥47.45	CN¥73.99 +55.9%	19.8%	CN¥109.00	CN¥51.00	n/a	14
Jul ’25	CN¥48.16	CN¥74.64 +55.0%	18.5%	CN¥109.00	CN¥60.00	n/a	14
Jun ’25	CN¥53.40	CN¥75.99 +42.3%	18.8%	CN¥109.00	CN¥60.00	n/a	15
May ’25	CN¥57.16	CN¥83.66 +46.4%	24.9%	CN¥125.00	CN¥60.00	n/a	15
Apr ’25	CN¥62.05	CN¥92.41 +48.9%	21.6%	CN¥125.00	CN¥60.00	n/a	16
Mar ’25	CN¥65.43	CN¥100.78 +54.0%	24.1%	CN¥142.00	CN¥60.00	n/a	15
Feb ’25	CN¥56.75	CN¥100.78 +77.6%	24.1%	CN¥142.00	CN¥60.00	n/a	15
Jan ’25	CN¥68.17	CN¥109.15 +60.1%	22.1%	CN¥160.00	CN¥71.00	n/a	15
Dec ’24	CN¥70.70	CN¥112.08 +58.5%	19.5%	CN¥160.00	CN¥81.60	n/a	15
Nov ’24	CN¥77.05	CN¥122.71 +59.3%	18.0%	CN¥160.00	CN¥87.00	CN¥52.34	15
Oct ’24	CN¥93.31	CN¥134.22 +43.8%	15.3%	CN¥181.00	CN¥105.00	CN¥62.42	15
Sep ’24	CN¥105.32	CN¥136.22 +29.3%	18.1%	CN¥181.00	CN¥93.00	CN¥42.05	15
Aug ’24	CN¥103.93	CN¥146.25 +40.7%	20.7%	CN¥197.00	CN¥93.00	CN¥47.45	15
Jul ’24	CN¥88.88	CN¥148.05 +66.6%	19.2%	CN¥197.00	CN¥93.00	CN¥48.16	15
Jun ’24	CN¥92.41	CN¥157.39 +70.3%	14.5%	CN¥197.00	CN¥118.00	CN¥53.40	15
May ’24	CN¥114.03	CN¥160.82 +41.0%	11.6%	CN¥197.00	CN¥132.00	CN¥57.16	15
Apr ’24	CN¥128.23	CN¥174.90 +36.4%	12.2%	CN¥221.00	CN¥145.00	CN¥62.05	15
Mar ’24	CN¥137.88	CN¥193.07 +40.0%	12.6%	CN¥229.00	CN¥158.00	CN¥65.43	14
Feb ’24	CN¥141.50	CN¥199.71 +41.1%	14.4%	CN¥264.00	CN¥159.00	CN¥56.75	14
Jan ’24	CN¥149.24	CN¥201.99 +35.3%	13.0%	CN¥264.00	CN¥162.50	CN¥68.17	14
Dec ’23	CN¥132.40	CN¥201.99 +52.6%	13.0%	CN¥264.00	CN¥162.50	CN¥70.70	14
Nov ’23	CN¥154.50	CN¥214.84 +39.1%	10.8%	CN¥264.00	CN¥171.00	CN¥77.05	15

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

Byhealth

CN¥20.9b

Develops and sells dietary supplements.

300146

CN¥12.40

7D

-3.9%

1Y

-32.3%

Shenzhen Breo Technology

CN¥2.5b

Researches and develops portable massage products for headache swelling, eye fatigue, and shoulder and neck pain.

688793

CN¥29.69

7D

-1.7%

1Y

-24.3%

SYoung Group

CN¥5.0b

Engages in the research and development, production, and sale of cosmetic products in China.

300740

CN¥12.30

7D

-4.1%

1Y

-27.0%

Yunnan Botanee Bio-Technology GroupLTD Valuation